Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 6/20 | 0.36 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 2/20 | 0.35 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.34 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.34 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28896390 | 0.89 | USP2 (0.37) | USP2SMN1; SMN2RORCDDB1CRBN | |
| SCHEMBL28896608 | 0.88 | RORC (0.36) | USP2SMN1; SMN2RORCTACR1CYP11B2 | |
| SCHEMBL31752520 | 0.86 | USP2 (0.39) | USP2SMN1; SMN2RORCTACR1CYP11B2 | |
| SCHEMBL24113337 | 0.85 | USP2 (0.41) | USP2SMN1; SMN2RORCTACR1CYP11B2 | |
| SCHEMBL29581801 | 0.85 | USP2 (0.41) | USP2SMN1; SMN2RORCTACR1CYP11B2 | |
| SCHEMBL24012213 | 0.85 | USP2 (0.41) | USP2SMN1; SMN2RORCTACR1CYP11B2 | |
| SCHEMBL28896661 | 0.84 | CYP4F2 (0.38) | USP2SMN1; SMN2RORCTACR1CYP11B2 | |
| SCHEMBL29211272 | 0.82 | RORC (0.37) | USP2SMN1; SMN2RORCTACR1CYP11B2 | |
| SCHEMBL31750904 | 0.81 | USP2 (0.39) | USP2SMN1; SMN2RORCTACR1CYP11B2 | |
| SCHEMBL28896586 | 0.80 | USP2 (0.40) | USP2SMN1; SMN2CYP11B2ACACBUSP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403584-A | 2-thio-2, 3-dihydropyrimidine-4-one derivative, pharmaceutical composition, preparation method and application thereof | 长春金赛药业有限责任公司 | 2022-11-29 | — | — | CN | disclosed |